B. Riley Raises Earnings Estimates for Rigel Pharmaceuticals
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL – Free Report) – Research analysts at B. Riley raised their FY2026 earnings per share (EPS) estimates for shares of Rigel Pharmaceuticals in a research report issued on Tuesday, March 4th. B. Riley analyst K. Patel now forecasts that the biotechnology company will post earnings of $1.08 per share for the […]
